
Cortisol is a glucocorticoid steroid hormone produced by the zona fasciculata of the adrenal cortex, released in response to activation of the hypothalamic-pituitary-adrenal (HPA) axis. It is the primary human stress hormone, coordinating the body's physiological response to physical and psychological challenges. Cortisol mobilizes energy, modulates immune function, regulates blood pressure, and sharpens attention — all in service of helping the organism meet acute challenges. In the context of psychoactive substances, cortisol is critically relevant because virtually every drug that significantly alters brain state also affects the HPA axis and cortisol output, and because the cortisol system profoundly influences the subjective quality of drug experiences.
Cortisol operates within a precise circadian rhythm: levels peak approximately 30–45 minutes after waking (the "cortisol awakening response," or CAR) and decline through the day to a nadir around midnight. This rhythm is driven by the suprachiasmatic nucleus in the hypothalamus and synchronized to light-dark cycles. Disruption of this rhythm — by shift work, irregular sleep, chronic psychological stress, or heavy substance use — is associated with impaired immune function, metabolic dysfunction, cognitive deficits, and mood disorders.
For the harm reduction community, cortisol has several areas of direct practical relevance. Acute psychedelic experiences, stimulant use, dissociative drug use, and even cannabis use are all associated with acute HPA axis activation and elevated cortisol. Chronic stress (reflected in chronically elevated cortisol) is a major trigger for drug use escalation and relapse. Understanding the cortisol system explains many aspects of the interaction between emotional state, stress, and drug effects — including why experiences are more likely to turn challenging when the user is already in a stressed or sleep-deprived state.
Exogenous glucocorticoids (prednisone, dexamethasone) are important medications used for autoimmune conditions and inflammation. Their side effects — anxiety, mood changes, sleep disruption, and HPA axis suppression — reflect exactly the consequences of sustained supraphysiological glucocorticoid signaling.